Passage Bio (PASG) Competitors $0.43 -0.02 (-5.39%) As of 02:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PASG vs. PROC, SGMT, IOBT, CABA, IMAB, SAVA, VXRT, CRDL, KRRO, and VIRIShould you be buying Passage Bio stock or one of its competitors? The main competitors of Passage Bio include Procaps Group (PROC), Sagimet Biosciences (SGMT), IO Biotech (IOBT), Cabaletta Bio (CABA), I-Mab (IMAB), Cassava Sciences (SAVA), Vaxart (VXRT), Cardiol Therapeutics (CRDL), Korro Bio (KRRO), and Virios Therapeutics (VIRI). These companies are all part of the "pharmaceutical products" industry. Passage Bio vs. Its Competitors Procaps Group Sagimet Biosciences IO Biotech Cabaletta Bio I-Mab Cassava Sciences Vaxart Cardiol Therapeutics Korro Bio Virios Therapeutics Procaps Group (NASDAQ:PROC) and Passage Bio (NASDAQ:PASG) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability. Is PROC or PASG more profitable? Procaps Group's return on equity of 0.00% beat Passage Bio's return on equity.Company Net Margins Return on Equity Return on Assets Procaps GroupN/A N/A N/A Passage Bio N/A -72.53%-52.10% Does the MarketBeat Community prefer PROC or PASG? Passage Bio received 50 more outperform votes than Procaps Group when rated by MarketBeat users. Likewise, 68.83% of users gave Passage Bio an outperform vote while only 37.50% of users gave Procaps Group an outperform vote. CompanyUnderperformOutperformProcaps GroupOutperform Votes337.50% Underperform Votes562.50% Passage BioOutperform Votes5368.83% Underperform Votes2431.17% Do analysts rate PROC or PASG? Passage Bio has a consensus price target of $7.50, suggesting a potential upside of 1,672.63%. Given Passage Bio's stronger consensus rating and higher probable upside, analysts clearly believe Passage Bio is more favorable than Procaps Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Procaps Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Passage Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation and earnings, PROC or PASG? Procaps Group has higher revenue and earnings than Passage Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProcaps Group$409.92M0.26$42.54MN/AN/APassage BioN/AN/A-$102.06M-$1.02-0.41 Do institutionals & insiders have more ownership in PROC or PASG? 53.5% of Passage Bio shares are held by institutional investors. 19.9% of Procaps Group shares are held by company insiders. Comparatively, 5.0% of Passage Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, PROC or PASG? Procaps Group has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500. Comparatively, Passage Bio has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. Does the media prefer PROC or PASG? In the previous week, Passage Bio had 1 more articles in the media than Procaps Group. MarketBeat recorded 1 mentions for Passage Bio and 0 mentions for Procaps Group. Passage Bio's average media sentiment score of 1.87 beat Procaps Group's score of 0.00 indicating that Passage Bio is being referred to more favorably in the news media. Company Overall Sentiment Procaps Group Neutral Passage Bio Very Positive SummaryPassage Bio beats Procaps Group on 9 of the 14 factors compared between the two stocks. Get Passage Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for PASG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PASG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PASG vs. The Competition Export to ExcelMetricPassage BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.30M$3.09B$5.59B$8.63BDividend YieldN/A1.57%5.28%4.18%P/E Ratio-0.3632.9427.2120.00Price / SalesN/A465.00411.62157.76Price / CashN/A168.6838.2534.64Price / Book0.213.417.114.70Net Income-$102.06M-$72.35M$3.24B$248.05M7 Day Performance-5.98%7.18%2.54%2.51%1 Month Performance37.24%17.64%8.76%6.17%1 Year Performance-58.92%-17.25%31.37%13.72% Passage Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PASGPassage Bio2.9601 of 5 stars$0.43-5.4%$7.50+1,628.9%-57.9%$26.96MN/A-0.37130Positive NewsGap DownPROCProcaps GroupN/A$0.95-40.3%N/A-62.7%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeSGMTSagimet Biosciences2.3745 of 5 stars$3.49-1.7%$22.40+541.8%+24.8%$107.06M$2M-1.988News CoverageIOBTIO Biotech4.0512 of 5 stars$1.62+14.1%$9.33+476.1%+13.6%$106.73MN/A-1.1830Positive NewsShort Interest ↓Gap UpHigh Trading VolumeCABACabaletta Bio2.8991 of 5 stars$2.06+10.2%$20.33+887.1%-84.2%$104.53MN/A-0.9650Trending NewsAnalyst ForecastAnalyst RevisionIMABI-Mab3.3577 of 5 stars$1.28-2.3%$5.50+329.7%+33.9%$104.53M$3.27M0.00380News CoveragePositive NewsGap DownSAVACassava Sciences4.2777 of 5 stars$2.13+6.0%$54.50+2,458.7%-88.9%$102.90MN/A-1.5430Positive NewsVXRTVaxart2.1121 of 5 stars$0.45+3.9%$3.00+566.7%-34.5%$102.70M$47.40M-1.10120Gap DownCRDLCardiol Therapeutics2.3466 of 5 stars$1.24-0.8%$8.67+598.9%-51.0%$102.44MN/A-3.1820Gap UpKRROKorro Bio3.5724 of 5 stars$10.80-5.4%$102.43+848.4%-64.8%$101.42M$4.82M-1.1470Positive NewsAnalyst RevisionHigh Trading VolumeVIRIVirios TherapeuticsN/A$5.18-2.1%$3.00-42.1%+2,104.8%$99.76MN/A-19.195 Related Companies and Tools Related Companies PROC Alternatives SGMT Alternatives IOBT Alternatives CABA Alternatives IMAB Alternatives SAVA Alternatives VXRT Alternatives CRDL Alternatives KRRO Alternatives VIRI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PASG) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.